We also observed elevated hepatic NEAT1 levels in NAFLD patients with inflammation and advanced fibrosis [69], providing additional support for a role of this lncRNA in fibrogenesis in mice and humans. The gene discussed is NEAT1; the disease is metabolic dysfunction-associated steatotic liver disease.